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OBJECTIVE — A1C levels have been shown to be elevated in relation to glycemia in late
pregnancy, although the precise mechanisms remain undetermined. We hypothesized that iron
deﬁciency is involved in the A1C increase in late pregnancy.
RESEARCH DESIGN AND METHODS — In study 1, A1C, serum glycated albumin,
erythrocyte indexes, and iron metabolism indexes were determined in 47 nondiabetic pregnant
women not receiving iron supplementation who were divided into four groups according to
gestational period (group I, 21–24 weeks; group II, 25–28 weeks; group III, 29–32 weeks; and
groupIV,33–36weeks).Instudy2,thesedeterminantswereobtainedattwogestationalperiods
(20–23 weeks and 32–33 weeks) in 17 nondiabetic pregnant women.
RESULTS — In study 1, A1C levels were higher in groups III and IV than those in groups I
and II, whereas serum glycated albumin levels were not different among these four groups.
Hemoglobin, mean corpuscular hemoglobin (MCH), serum transferrin saturation, and serum
ferritin were lower in groups III and IV. A1C levels were negatively correlated with MCH, serum
transferrin saturation, and serum ferritin. In study 2, A1C levels were signiﬁcantly increased at
gestationalweeks32–33fromthoseatweeks20–23,whereasserumglycatedalbuminlevelsdid
not differ between the two gestational periods. MCH, serum transferrin saturation, and serum
ferritin were decreased at gestational weeks 32–33. A1C levels showed a negative correlation
with MCH, serum transferrin saturation, and serum ferritin.
CONCLUSIONS — A1C levels were elevated in late pregnancy owing to iron deﬁciency.
Serum glycated albumin may offer a better index for monitoring glycemic control in pregnancy.
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I
n pregnant women displaying diabetes
and women with gestational diabetes
mellitus, intensive glycemic control
during pregnancy is needed to lower the
risk of intrauterine fetal death, fetal
growth disorders, and maternal compli-
cations(1,2).Theextentofnonenzymatic
glycation of proteins increases in diabetic
patients. Of these glycated proteins, A1C
is widely used as the current standard
marker for monitoring chronic glycemic
control (3,4) and represents an important
target for treatment of diabetic patients
(5). Phelps et al. (6) showed biphasic
changes in A1C levels during pregnancy,
with A1C levels being lowest at gesta-
tional week 24. A longitudinal study also
demonstrated similar biphasic changes in
A1C levels (7).
A1C measurements are known to be
profoundly affected by erythrocyte turn-
over, as are plasma glucose levels (8,9).
Blood dilution–related anemia is known
to be frequently observed in pregnancy.
In late pregnancy, iron deﬁciency anemia
is also often observed, caused by the in-
creaseddemandsforiron(10).A1Clevels
have been shown to be higher in relation
to glycemia in patients with iron deﬁ-
ciency anemia (11–13). We have recently
shown that A1C levels are higher in pre-
menopausal women with an iron-
deﬁcient state, even in the absence of
anemia (14). We therefore hypothesized
thatA1Clevelsaresethigherinrelationto
glycemia in late pregnancy, during which
most women are iron deﬁcient. To
conﬁrm this possibility, we studied the
relationship between A1C and iron me-
tabolisminnondiabeticpregnantwomen.
For clinical issues, a study performed in
pregnant diabetic women is important.
However, in diabetic women ﬂuctuations
of plasma glucose may directly inﬂuence
A1C levels beyond the effect of iron me-
tabolism,makingitdifﬁculttoanalyzethe
directeffectsofgestationalcourseonA1C
levels. Thus, in this study, we aimed to
examine the relationship between A1C
andironmetabolisminnondiabeticpreg-
nant women, in whom the inﬂuence of
plasma glucose levels is minimal. Serum
glycatedalbumin,adifferentindicatorfor
chronic glycemia, was also studied in
these subjects.
RESEARCH DESIGN AND
METHODS— In a cross-sectional
study (study 1), we studied 47 pregnant
Japanese women at gestational weeks 21–
36. All subjects had been seen at Aizen-
bashi Hospital from February to July
2007, and ambulatory plasma glucose
levels were 100 mg/dl. Mean  SD age
was29.55.7years.Allsubjectshadnot
been and were not receiving iron and
vitamin supplementations during preg-
nancy. Subjects were divided into four
groups according to gestational period:
group I (n  20), gestational weeks 21–
24; group II (n  9), gestational weeks
25–28; group III (n  11), gestational
weeks 29–32; and group IV (n  7),
gestational weeks 33–36. A1C, erythro-
cyte(redbloodcell[RBC])count,hemat-
ocrit, hemoglobin, mean corpuscular
volume (MCV), mean corpuscular he-
moglobin (MCH), serum iron, serum
transferrin saturation, serum ferritin,
and glycated albumin were determined.
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studied 17 nondiabetic pregnant women
whohadbeenseenatAizenbashiHospital
between February and July 2007. Their
age was 28.0  5.7 years. A1C, RBC
count, hematocrit, hemoglobin, MCV,
MCH, serum iron, serum transferrin sat-
uration, serum ferritin, and serum gly-
cated albumin were determined at two
periods (gestational weeks 20–23 and
32–33).
For control subjects, 19 age-matched
nonpregnant healthy women whose age
was 27.7  2.0 years were also studied.
Theinvestigationsreportedherewere
performed in accordance with the princi-
ples of the Declaration of Helsinki as re-
vised in 2000. The institutional review
board approved this study, and all pa-
tientsprovidedwritteninformedconsent.
Laboratory methods
A1C was measured by latex aggregation
immunoassay using Determiner HbA1C
(KyowaMedix,Tokyo,Japan),whichwas
found not to be inﬂuenced by hemoglo-
bin F and other minor hemoglobin spe-
cies (15), with calibration using Japan
Diabetes Society Lot 2 (16). Inter- and in-
tra-assay coefﬁcients of variation were
0.98 and 0.97%, respectively. Serum gly-
cated albumin was determined by enzy-
matic methods using albumin-speciﬁc
protease, ketoamine oxidase, and albu-
min assay reagent (Lucica GA-L; Asahi
Kasei Pharma, Tokyo, Japan) (17). Blood
cell counts, hematocrit, hemoglobin,
MCV,andMCHweremeasuredbyanau-
tomated hematology system. Serum iron
and unsaturated iron-binding capacity
were determined by a calorimetric
method. Serum ferritin concentrations
were measured by a chemiluminescent
immunoassay method. Total iron-
binding capacity and serum transferrin
saturation were calculated by adding un-
saturated iron-binding capacity to serum
iron and dividing serum iron by total
iron-binding capacity, respectively. All
tests were performed in a central labora-
tory at Aizenbashi Hospital.
Statistical analyses
Data are shown as means  SD for con-
tinuous variables and as numbers for
categorical variables. Unadjusted com-
parisons for continuous variables were
performed among groups I–IV using
ANOVA, and unpaired t tests were used
to estimate the level of signiﬁcance of dif-
ferences between means. To evaluate re-
lationships between A1C levels and
differentvariables,singlelinearunivariate
regression analyses were performed. In
study 2, paired t tests were used to com-
pare two groups. The StatView computer
program (version 5.0 for Windows; Aba-
cus Concepts, Berkeley, CA) was used for
all statistical analyses. Values of P  0.05
were considered statistically signiﬁcant.
RESULTS— Figure 1 shows A1C and
glycated albumin levels in pregnant
women divided into four groups accord-
ing to gestational period. The results
show that A1C levels were higher in
groups III (29–32 weeks) and IV (33–36
weeks) than in groups I (21–24 weeks)
and II (25–28 weeks). Glycated albumin
Figure 1— A1C (A) and serum glycated albumin (GA) (B) levels in 47 pregnant women (study
1) divided according to gestational period into group I (21–24 weeks; n  20), group II (25–28
weeks;n9),groupIII(29–32weeks;n11),andgroupIV(33–36weeks;n7).*P0.001
versus group I; #P  0.05 versus group II; ##P  0.01 versus group II.
Figure 2— RBC counts (A), hemoglobin (B), MCH (C), serum transferrin (Tf) saturation (D),
andserumferritin(E)in47pregnantwomen(study1)dividedaccordingtogestationalperiodinto
groupI(21–24weeks;n20),groupII(25–28weeks;n9),groupIII(29–32weeks;n11),
and group IV (33–36 weeks; n  7). *P  0.05 versus group I; **P  0.001 versus group I; #P 
0.05 versus group II.
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groups. RBC counts did not differ among
the four groups of pregnant women.
However, hemoglobin, MCH, transferrin
saturation, and serum ferritin levels were
lower in groups III and IV (Fig. 2). A1C
levels were negatively correlated with
MCH, serum transferrin saturation, and
serum ferritin (Fig. 3).
Next, we studied 17 pregnant indi-
viduals at two periods during middle
pregnancy (20–23 weeks) and late preg-
nancy (32–33 weeks). A1C levels signiﬁ-
cantly increased from middle pregnancy
(4.4  0.2%) to late pregnancy (4.8 
0.2%; P  0.0001), whereas serum gly-
catedalbuminlevelsdidnotchange(from
13.9  1.2 to 13.9  1.0%; P  0.7029)
(Fig. 4). RBC counts were unchanged
during both periods (365  26  10
6/l
in middle pregnancy vs. 367  20 
10
6/l in late pregnancy; P  0.6630),
whereas MCH (30.2  1.5 vs. 28.8  2.4
pg; P  0.0016), transferrin saturation
(21.7  10.4 vs. 12.5  7.9%; P 
0.0011), and serum ferritin (17.4  14.3
vs. 5.8  3.5 ng/ml; P  0.0022) were
decreased in late pregnancy compared
with values in middle pregnancy. Hemo-
globin levels were also decreased but of
borderline signiﬁcance (from 11.0  0.5
to 10.6  0.9 g/dl; P  0.0555). When
iron deﬁciency was deﬁned as serum fer-
ritin 15 ng/ml, this condition was
presentin35%ofwomeninmiddlepreg-
nancy and 95% in late pregnancy. A1C
levels were negatively correlated with
MCH, transferrin saturation, and serum
ferritin (Fig. 5).
In our study 2, the mean A1C level of
17 women in late pregnancy (32–33
weeks) was not signiﬁcantly different
fromthatof19age-matchednonpregnant
women (4.8  0.2 vs. 4.8  0.2%).
CONCLUSIONS— We hypothe-
sized that changes in A1C levels during
pregnancy are at least partially attribut-
able to iron deﬁciency, as pregnant
women are often iron deﬁcient and iron
deﬁciency is known to inﬂuence A1C lev-
els (14). In studies 1 and 2, MCH, serum
transferrin saturation, and serum trans-
ferrin were found to be lower in pregnant
women at later stages of gestation. In ad-
dition, A1C levels showed a negative cor-
relation with MCH, serum transferrin
saturation, and serum transferrin. On the
basisoftheseobservations,theincreasein
A1C levels in late pregnancy seems to be
mainly attributable to an iron-deﬁcient
status at this period. To the best of our
knowledge, this is the ﬁrst study to dem-
onstrate the involvement of iron deﬁ-
ciency in increased A1C levels in late
pregnancy.
In both the cross-sectional study
(study 1) and longitudinal study (study
2), we found that A1C levels were in-
creased in late pregnancy. Serum gly-
cated albumin levels, by contrast, were
unchanged during the gestational
course. These results suggest that the
increase in A1C levels in late pregnancy
is unrelated to changes in plasma glu-
cose levels. Phelps et al. (6) have shown
biphasic changes in A1C levels during
pregnancy, with a nadir at gestational
week 24. They also demonstrated bi-
phasic changes in 1-h glucose levels for
the 50-g oral glucose tolerance test dur-
ingpregnancy,withanadirat20weeks.
Those results suggest that changes in
plasma glucose levels are followed by
changes in A1C levels during pregnancy.
However, changes in plasma glucose levels
were relatively small compared with
changesinA1Clevels.ChangesinA1Clev-
els during pregnancy may thus result from
factors other than plasma glucose levels
alone. In this regard, Cousins et al. (18)
showedthatplasmaglucoselevelswereun-
changed from middle to late pregnancy.
Supplementation with iron is rec-
ommended for pregnant women with
iron deﬁciency anemia (10). In patients
with iron deﬁciency anemia, A1C levels
have been shown to temporarily de-
crease after treatment with iron (19).
Thus, in patients with iron deﬁciency
anemia, whether treated or not, A1C is
inadequate as an indicator to accurately
reﬂect glycemic control. Whether A1C
levels are relatively stable in pregnant
women who are continuously receiving
iron supplementation from early preg-
nancy should be investigated.
In contrast with the results of Nielsen
et al. (20) demonstrating that A1C levels
were decreased early in pregnancy and
Figure 3— Association of A1C levels with MCH (A), serum transferrin (Tf) saturation (B), and
serum ferritin (C) in 47 pregnant women (study 1).
Figure 4— A1C (A) and serum glycated albumin (GA) (B) levels in 17 pregnant women (study
2) studied in middle pregnancy (20–23 weeks) and late pregnancy (32–33 weeks).
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pared with those in nonpregnant women,
we showed that A1C levels increased in
that period. The reasons for the differ-
ences from our results are unclear. Our
Japanese women may behave differently
during pregnancy than the Danish
women with regard to iron metabolism.
Differences in iron supplementation sta-
tus, which was not demonstrated in the
article by Nielsen et al. (20), may cause
the different results.
Serum fructosamine levels report-
edly decrease as gestation progresses
(21,22). Serum fructosamine reﬂects
the total amount of glycated serum pro-
teins. Measurement is thus inﬂuenced
when serum protein levels are altered.
In pregnant women, serum protein lev-
els decrease by dilution, resulting in de-
creased serum fructosamine levels.
Serum fructosamine is thus also inade-
quate for monitoring chronic glucose
control in pregnancy. In contrast, be-
cause serum glycated albumin is mea-
sured as the ratio of serum glycated
albumin to serum albumin, measure-
ment is not inﬂuenced by serum albu-
min levels. Serum glycated albumin
levels decrease slightly from early to
middle pregnancy (21). These changes
resemble those of A1C levels, probably
reﬂecting changes in plasma glucose
levels during these periods. However,
we found that serum glycated albumin
levels were unaltered from middle to
late pregnancy.
The present study reveals that iron
deﬁciency is involved in increased A1C
levels in late pregnancy. Our results
suggest that caution is warranted in inter-
pretation of A1C in late pregnancy. Con-
versely, serum glycated albumin may
offer a better index for monitoring glyce-
mic control in pregnancy. The present
study was performed in pregnant women
without diabetes, although gestational di-
abetes mellitus was not completely ruled
out. Further studies on pregnant women
with diabetes will make our observations
useful for clinical management of these
patients.
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